Beclomethasone Dipropionate + SalbutamolThird Party Manufacturing in India

Beclomethasone Dipropionate + Salbutamol works by treating both the underlying inflammation and the immediate smooth muscle constriction in the pulmonary tract. Beclomethasone dipropionate decreases airway hyperresponsiveness, while salbutamol relaxes bronchial smooth muscle by stimulating beta-2 receptors. It activates adenyl cyclase to help the body clear obstructed airways and restore ventilation. Unlike monotherapy, it treats the underlying disease pathology while addressing acute symptoms. It is highly effective and well-tolerated.

Therapeutic Uses

• Reversible Obstructive Airway Disease: Controls symptoms in patients requiring regular corticosteroid and bronchodilator therapy.
• Severe Bronchial Asthma: Lowers incidence of acute emergency asthma attacks.

Why Manufacturers Choose Beclomethasone Dipropionate + Salbutamol

Partnering for Beclomethasone Dipropionate + Salbutamol third party manufacturing in India yields excellent commercial returns, given the baseline popularity of these standard molecules. Production takes place in state-of-the-art aerosol facilities operating under WHO-GMP specifications. The combination provides an affordable, highly reliable respiratory solution using well-established chemical profiles like CAS 5534-09-8.